Extracellular proteins of Cryptococcus neoformans and host antibody response

Infection and Immunity

Volumn 65, Issue 7, 1997, Pages 2599-2605

  Chen, Lin Chi ^a   Pirofski, Liise Anne ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; BETA GLUCOSIDASE; ESTERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTORADIOGRAPHY; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HOST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SUPERNATANT;

EID: 0030914029     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.7.2599-2605.1997     Document Type: Article

References (59)

1. Aoki, S., S. Ito-Kuwa, K. Nakamura, J. Kato, K. Ninomiya, and V. Vidotto. 1994. Extracellular proteulytic activity of Cryptococus neoformans, Mycopathologia 128:143-150.
2. Baca, O. G., M. J. Roman, R. H. Glew, R. F. Christner, J. E. Buhler, and A. S. Aragon. 1993. Acid phosphatase activity in Coxilla burnetii: a possible virulence factor. Infect. Immun. 61:4232-4239.
3. Belay, T., and R. Cherniak. 1995. Determination of antigen binding specificities of Cryptococcus neformans factor sera by enzyme-linked immunosorbent assay. Infect. Immun. 63:1810-1819.
4. Belay, T., R. Cherniak, E. B. O'Neill, and T. R. Kozel. 1996. Serotyping of Cryptococcus neoformans by dot enzyme assay. J. Clin. Microbiol. 34:466-470.
5. Bennett, J. E. 1981. Cryptococcal skin test antigen: preparation variable and characterization. Infect. Immun. 32:373-380.
6. Bhattacharjee, A. K., K. J. Kwon-Chung, and C. P. J. Glaudemans. 1979. The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D. Carbohydr. Res. 73:183-192.
7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-54.
8. Buchanan, K. L., and J, W. Murphy. 1993. Characterization of cellular infiltrates and cytokine production during the expression phase of the anti-cryptococcal delayed-type hypersensitivity response. Infect. Immun. 61:2854-2865.
9. Casai, M., and M. J. Linares. 1983. Contribution to the study of the enzymatic profiles of yeast organisms with medical interest. Mycopathologia 81:155-159.
10. Chang, Y. C., L. A. Penoyer, and K. J. Kown-Chung. 1996. The second capsule of Cryptococcus nevformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983.
11. Chen, L.-C., E. S. Blank, and A. Casadevall. 1996. Extracellular proteinase activity of Cryptocccus neoformans. Clin. Diagn. Lab. Immunol. 3:570-574.
12. Cherniak, R., E. Reiss, and S. H. Turner. 1982. A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr. Res. 103:239-250.
13. Cherniak, R., and J. B. Sundstrom. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
14. Commenil, P., L. Belingheri, and M. S. Dehorter. 1995. Purification and properties of an extracellular lipase from the fungus Botrytis cinerea. Lipids 30:351-356.
15. Currie, B. P., and A, Casadevall. 1994. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:1029-1033.
16. Currie, B. P., L. R. Freundlich, and A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptocccus neoformanss isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32:1188-1192.
17. Curtis, J. L., G. B. Huffnagle, G. H. Chen, M. L. Warnock, M. Gyetko, R. McDonald, P. Scott, and G. B. Toews. 1994. Experimental murine pulmonary cryptococcosis. Lab. Invest. 71:113-126.
18. De Reuck, J. L., W. J. P. De Coster, and H. M. van der Eecken. 1986. Acid phosphatase activity of cerebrospinal fluid cells in bacterial and abacterial meningitis, Eur. Ncurol. 25:362-368.
19. Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol. 158:790-799.
20. Fromtling, R. A., H. J. Shadomy, and E. S. Jacobson. 1982. Decreased virulence in stable acapsulur mutants of Cryptococcus neoformans. Mycopathologia 79:23-29.
21. Goldman, D., S, C. Lee, and A. Casadevall. 1994. Pathogenous of pulmonary Cryptococcus neoformans infection in the rat. Infect. Immun. 62:4755-5761.
22. Goodley, J. M., and A. J. Hamilton. 1993. A novel extracellular high molecular weight proteinase from Cryptococcus neoformans, ahstr. P1-3. In Abstracts of the 2nd International Conference on Cryptococcus and Cryptococcocis.
23. Graybill, J. R., D. C. Straus, T. J. Nealon, M. Hague, and R. E. Paque. 1982. Immunogenic fractions of Cyptococcus neoformans. Mycopathologia 78:31-39.
24. Hamilton, A. J., M. A. Bartholomew, J. Figueroa, L. E. Fenelon, and R. J. Hay. 1991. Production of species-specific murine monoclonal antibodies against Ceyptococcus neoformans which recognize a noncapsular exoantigen. J. Clin. Microbiol. 29:980-984.
25. Hamilton, A. J., and J. Goodley. 1993. Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by immune sera. J. Clin. Microbiol. 31:335-339.
26. Hamilton, A. J., L. Jeavons, P, Hobby, and R. J. Hay. 1992. A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen hearing a glycosylaled species-specific epitope. Infect. Immun. 60:143-149.
27. Hay, R. J., and E. Reiss. 1978. Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans. Infect. Immun. 22:72-79.
28. Hoag, K. A., N. E. Street, G. b. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am, J. Respir. Cell. Mol. Biol. 13:487-495.
29. Ibrahim, A. S., F. Mirbod, S. G. Filler, Y. Banno, G. T. Cole, Y. Kitajima, J. E. Edwards, Jr., Y. Nozawa, and M. A. Ghannoum. 1995. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63:1993-1998.
30. Ito, A., A. Mukaiyama, Y. Itoh, K. Nagase, I. B. Thogersen, J. J. Enghild, Y. Sasaguri, and Y. Mori. 1996. Degradation of interleukin 1β by matrix metalHarrellloproteinases. J. Biol. Chem. 271:14657-14660.
31. Jacobson, E. S., D. J. Ayers, A. C. Harrell, and C. C. Nicholas. 1982. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J. Bacteriol. 150:1292-1296.
32. Jacobson, E. S., and M. J. Tingler. 1994. Strains of Cryotococcus neoformans with defined capsular phenotypes. J. Med. Vet. Myeol. 32:401-404.
33. Kalina, M., J. J. Bubis, A. S. Y. Kletter, and M. Aronson. 1970. Ultrastructural localization of acid phosphalase in the yeast Cryptococcus neoformans. Experientia 26:287-288.
34. Konig, B., K.-E. Jaeger, A. E. Sage, M. L. Vasil, and W. Konig. 1996. Role of Pseudonmonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes. and monocytes). Infect. Immun. 64:3252-3252-3258.
35. Kozel, T. R. 1983. Dissociation of a Hydrophobic surface from phagocytosis of encapsulated and nonencapsulated Cryptococcus neofomums. Infect. Immun. 39:1214-1219.
36. Kozel, T. R., M.A.Wilson, and J.W. Murphy. 1991. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect. Immun. 59:3101-3110.
37. Maeda, H., and T. Yamamoto. 1996. Pathogenic mechanisms induced by microbial proteases in microbial infections. Biol. Chem. Hoppe-Seyler 377:217-226.
38. Mahvi, T. A., S. S. Spicer, and N. J. Wright. 1974. Cytochemistry of acid mucosubstance and acid phosphatase in Cryptococcus neoformans. Can. J. Microbiol. 20:833-838.
39. Mirbod, F., Y. Banno, M. A. Ghannoum, A. S. Ibrahim, S. Nakashima, Y. Kitajima, G. T. Cole, and Y. Nozawa. 1995. Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim. Biophys. Acta 1257:181-188.
40. Mody, C. H., K. L. Sims, C. J. Wood, R. M. Syme, J. C. L. Spurrel, and M. M. Sexton, 1996. Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate. Infect. Immun. 64:4811-4814.
41. Mukherjee, J., L.-A. Pirofski, M. D. Scharff, and A. Casadevall. 1993. Antibody-mediated protection in mice with lethal intracerebral Cryptycoccus neoformam infection. Proc. Natl. Acad. Sci. USA 90:3636-3640.
42. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
43. Murphy, J. W., and G. C. Cozad. 1972. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolylic plaque technique. Infect. Immun. 5:896-401.
44. Murphy, J. W., J. A. Gregory, and H. W. Larsh. 1974. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect. Immun. 9:404-404.
45. Murphy, J. W., R. L. Mosley, R. Cherniak, G. H. Reyes, T. R. Kozel, and E. Reiss. 1988. Serological, electrophoretic. and biological properties of Cryptococcus neoformans antigens. Infect. Immun. 56:424-431.
46. Murphy, J. W., and N. Pahlavan. 1974. Cryptococcal culture filtrate antigen for detection of delayed-lype hypersensitivity in cryptococcosis. Infect. Immun. 25:284-242.
47. Perfect, J. R., M. M. Hobbs, D. L. Granger, and D. T. Duracek. 1988. Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect. Immun. 56:844-854.
48. 47a.Pirofski, L. Unpublished data.
49. Reilly, J. J., G. S. Baron, F. E. Nano, and M. S. Kuhlenschmidt. 1946. Characterization and sequence of a respiratory burst inhibiting acid phosphatase from Frandsella tularensis. J. Biol. Chem. 271:10473-10483.
50. Keiss, E., R. Cherniak, R. Eby, and L. Kaufman. 1984. Enzyme immunoassay detection of IgM to galactoxylomannan of Crptococcus neoformans. Diagn. Immunol. 2:109-115.
51. Koss, A., and I. E. P. Taylor. 1981. Extracellular glycoprotein from virulent and avirulent Cryptococcus species. Infect. Immun. 31:911-918.
52. Saha, A. K., J. N. Dowling, K. L. LaMarco, S. Das, A. T. Remaley, N. Olomu. M. T. Pope, and R. H. Glew. 1985. Properties of an acid phosphatasc from Legionella micdadi which blocks Superoxide union production by human neutrophils. Arch. Biochem. Biophys, 243:150-160.
53. Sakata, Y., T. Akaike, M. Suga, S. Ijiri, M. Ando, and H. Maeda. 1996. Bradykinin generation triggered by Pseudumonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol. Immunol. 40:415-423.
54. Tsuboi, R., H. Komatsuzaki, and H. Ogawa. 1996. Induction of an extracellular esterase from Candida albicans and some of its properties. Infect. Immun. 64:2936-2940.
55. Turner, S. H., R. Cherniak, and E. Reiss. 1984. Fractionation and characterization of galactoxylomannan from Cryptococus neoformans. Carhohydr. Res. 125:343-349.
56. Vartivarian, S. E., G. H. Reyes, E. S. Jacobson, P. G. James, R. Cherniak, V. R. Mumaw, and M. J. Tingler. 1989. Localization of mannoprotein in Cryptococcus neoformans. J. Bacteriol. 171:6850-6852.
57. Wang, Y., P. Aisen, and A. Casadevall. 1996. Melanin. Melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64:2420-2424.
58. Wang, Y., and A. Casadevall. 1994. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 62:3004-3007.
59. Wickes, B. L., D. E. Moore, and J. J. Kwon-Chung. 1994. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neuformans. Microbiology 140:543-555.